All Posts: cancer research
-
Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 18, 2019) — The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end of numerous failed attempts to improve survival for those with the deadly disease. “Atezolizumab, […]
Category: News Release
-
Facing a Difficult Diagnosis, Why One Patient Chooses to Confront Cancer at Georgetown Lombardi
(March 7, 2019) — While living in Chattanooga, Tenn., Adam Skipper was one of the primary caregivers for his 69-year-old mother before pancreatic cancer took her life. In October 2018, almost two years to the day of his mother’s death, Skipper was diagnosed with the same disease. “It was just a massive blow,” says Lee […]
Category: GUMC Stories
-
Carnegie Renews Classification of Georgetown as ‘Very High Research University’
Category: GUMC Stories
-
Large Study Reveals Long-Term Outcomes for Prostate Cancer Patients Treated with High Dose, Short Term Radiation
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (February 8, 2019) — A large national study examining a radiation treatment for prostate cancer — popular because it delivers a high dose of therapy in a very short time frame — supports its routine use. The study, conducted at cancer centers around the country including at Georgetown Lombardi Comprehensive Cancer Center, looks at long-term […]
Category: News Release
-
First Patient in a Clinical Trial Using Her Own Blood to Personalize Treatment for Non-Hodgkin Lymphoma Experiencing Remission
(January 11, 2019) — The first cancer patient to be treated as part of the CAR-T cell clinical trial at MedStar Georgetown University Hospital through Georgetown Lombardi Comprehensive Cancer Center is now in “complete remission.” Daisy Diggs, 57, of Laurel, Md., volunteered for the experimental treatment after a lengthy battle with stage-three non-Hodgkin lymphoma, a type […]
Category: GUMC Stories
-
Giving Patients A Voice in Breast Cancer Research
(January 4, 2019) — Soon after Hillary Stires, PhD, came to Georgetown Lombardi as a postdoctoral fellow, she started a grant application and asked for feedback from the Georgetown Breast Cancer Advocates (GBCA), a volunteer group of breast cancer survivors dedicated to supporting and promoting breast cancer research. Her experience was transformative. After Stires presented her plan […]
Category: GUMC Stories
-
Georgetown Lombardi’s Louis M. Weiner, MD, Named a National Academy of Inventors Fellow
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (December 11, 2018) — The National Academy of Inventors (NAI) has named Louis M. Weiner, MD, director of Georgetown Lombardi Comprehensive Cancer Center, to its 2018 class of fellows. According to the NAI, election to NAI Fellow status is the “highest professional distinction accorded to academic inventors who have demonstrated a prolific spirit […]
Category: News Release
-
Ruesch Center and OncLive Recognize Former VP Biden at the Luminary Awards
(December 9, 2018) — Former Vice President Joe Biden was among those who were recognized for improving the lives of patients with gastrointestinal cancer at the Second Annual Luminary Awards, hosted by the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center and OncLive. “Each of these recipients have made transformative […]
Category: GUMC Stories
-
Lynce Receives Potter Award for Early Career Research
(November 21, 2018) — In the ten years since coming to the U.S. from Portugal to complete her medical training, Filipa Lynce, MD, has conducted clinical trials to establish safe and effective cancer treatments for minority patients, including African Americans and Latinas, and studied the genetic differences in cancers among patients of different ethnicities. Now a medical […]
Category: GUMC Stories
-
Lombardi Gala Celebrates Its Founder’s Legacy
(November 20, 2018) — Each year, when the Margaret Hodges Leadership Award is bestowed on an individual who has demonstrated exceptional dedication to Georgetown Lombardi Comprehensive Cancer Center, recipients have expressed their admiration of Margaret Hodges, who helped found the Lombardi Gala. At this year’s 32nd Annual Lombardi Gala, those words of admiration carried an even […]
Category: GUMC Stories